Global Pharma Modernises Archiving with CARA Platform
This is a thin landing page describing an unnamed global pharmaceutical company that faced outdated document-archiving infrastructure, managing 13 terabytes of content and 65 million documents across two repositories, with ongoing archive requests continuing during migration. It implemented the CARA Platform to modernize archiving, reduce costs, and eliminate redundancy while meeting regulatory requirements. Beyond these scope figures, the visible page provides no further outcome metrics -- fuller detail is only in a linked case study document that was not part of the fetched page.
The customer is anonymised in Generis’s own case study — not withheld by us.
Generis makes the CARA platform, the regulatory/quality/clinical content backbone used by major pharma companies, now with AI document-classification features built in.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Generis on its own site — read the original case study on caralifesciences.generiscorp.com ↗
Related use cases
- 01Replacing Legacy Systems at Scale: Bayer's Global Migration to the CARA Platform
- 02Merck: Consolidating 12 Siloed Solutions to a Single Platform with CARA
- 03Swixx Biopharma Consolidates QMS, RIM, and Safety Processes on the CARA Life Sciences Platform
- 04Cheplapharm: Pharma Company Unify Processes with the CARA Life Sciences Platform
- 05Pfizer Case Study
- 06Transforming Content Operations for 2x Faster Time to Market